share_log

Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know

Benzinga ·  Jun 22 00:01

7 analysts have shared their evaluations of OptimizeRx (NASDAQ:OPRX) during the recent three months, expressing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings25000
Last 30D01000
1M Ago00000
2M Ago11000
3M Ago13000

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.0, a high estimate of $17.00, and a low estimate of $13.00. Surpassing the previous average price target of $14.25, the current average has increased by 5.26%.

price target chart

Exploring Analyst Ratings: An In-Depth Overview

An in-depth analysis of recent analyst actions unveils...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment